Literature DB >> 19869133

STUDIES IN THE COMMON COLD : I. OBSERVATIONS OF THE NORMAL BACTERIAL FLORA OF NOSE AND THROAT WITH VARIATIONS OCCURRING DURING COLDS.

G S Shibley1, F M Hanger, A R Dochez.   

Abstract

1. The normal bacterial flora of the nose and throat of thirteen individuals has been studied over periods ranging from 5 to 9 months. 2. Observations have been made of qualitative and quantitative changes in the flora occurring in the course of colds and of throat infections appearing in the group. 3. The normal basic nasal flora includes Staphylococcus albus, diphtheroids, and for certain individuals Staphylococcus aureus and citreus. Occasional transient bacteria are Gram-negative cocci and non-hemolytic streptococci. 4. The normal basic throat flora includes Gram-negative cocci, non-hemolytic streptococci, and for certain individuals "large Gram-positive cocci," B. influenzae, Bacillus "X," and diphtheroids. Transient organisms are Staphylococcus albus, hemolytic streptococci,Staphylococcus aureus and citreus, and pneumococci. 5. No bacteria were found in early cold cultures to which a causative rôle could be assigned. 6. In the course of colds the basic flora of the nose was often scanty in the early stages. The throat showed reduction of prominence or alterations in predominance of the basic flora. 7. Certain organisms were prominent in colds, usually as late or secondary invaders, these included Staphylococcus aureus, hemolytic streptococci, and B. influenzae. 8. There was a striking increase in the incidence of hemolytic streptococci in throat infections.

Entities:  

Year:  1926        PMID: 19869133      PMCID: PMC2131103          DOI: 10.1084/jem.43.3.415

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  5 in total

1.  Observations ON THE BACTERIOLOGY OF CHRONIC NASAL CATARRH AND ITS TREATMENT BY AUTOGENOUS VACCINES.

Authors:  L Mackey
Journal:  Br Med J       Date:  1919-08-09

2.  EXPERIMENTAL STUDIES OF THE NASOPHARYNGEAL SECRETIONS FROM INFLUENZA PATIENTS : IX. THE RECURRENCE OF 1922.

Authors:  P K Olitsky; F L Gates
Journal:  J Exp Med       Date:  1922-10-31       Impact factor: 14.307

3.  AN IMPROVED ANAEROBE JAR.

Authors:  J H Brown
Journal:  J Exp Med       Date:  1921-05-31       Impact factor: 14.307

4.  STUDIES ON THE NASOPHARYNGEAL SECRETIONS FROM PATIENTS WITH COMMON COLDS.

Authors:  P K Olitsky; J E McCartney
Journal:  J Exp Med       Date:  1923-09-30       Impact factor: 14.307

5.  THE OCCURRENCE OF BACILLUS INFLUENZAE IN THROATS AND SALIVA.

Authors:  I W Pritchett; E G Stillman
Journal:  J Exp Med       Date:  1919-02-28       Impact factor: 14.307

  5 in total
  6 in total

1.  STUDIES IN THE COMMON COLD : II. A STUDY OF CERTAIN GRAM-NEGATIVE FILTER-PASSING ANAEROBES OF THE UPPER RESPIRATORY TRACT.

Authors:  K C Mills; G S Shibley; A R Dochez
Journal:  J Exp Med       Date:  1928-01-31       Impact factor: 14.307

2.  THE ETIOLOGY OF ACUTE UPPER RESPIRATORY INFECTION (COMMON COLD).

Authors:  P H Long; J A Doull; J M Bourn; E McComb
Journal:  J Exp Med       Date:  1931-03-31       Impact factor: 14.307

3.  STUDIES ON THE COMMON COLD : V. THE RELATIONSHIP OF PATHOGENIC BACTERIA TO UPPER RESPIRATORY DISEASE IN INFANTS.

Authors:  Y Kneeland; C F Dawes
Journal:  J Exp Med       Date:  1932-04-30       Impact factor: 14.307

4.  THE ASSOCIATION OF PNEUMOCOCCI, HEMOPHILUS INFLUENZAE, AND STREPTOCOCCUS HEMOLYTICUS WITH CORYZA, PHARYNGITIS, AND SINUSITIS IN MAN.

Authors:  L T Webster; A D Clow
Journal:  J Exp Med       Date:  1932-02-29       Impact factor: 14.307

5.  STUDIES IN THE COMMON COLD : IV. EXPERIMENTAL TRANSMISSION OF THE COMMON COLD TO ANTHROPOID APES AND HUMAN BEINGS BY MEANS OF A FILTRABLE AGENT.

Authors:  A R Dochez; G S Shibley; K C Mills
Journal:  J Exp Med       Date:  1930-10-31       Impact factor: 14.307

6.  STUDIES ON THE COMMON COLD : III. THE UPPER RESPIRATORY FLORA OF INFANTS.

Authors:  Y Kneeland
Journal:  J Exp Med       Date:  1930-03-31       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.